Objectives

After participating in this educational activity, attendees should be able to:
1| Describe aldosterone pathways with particular focus on its non-genomic end-organ effects
2| Explain opportunities to utilize mineralocorticoid receptor agonism in the management of hypotension from autonomic dysfunction
3| Interpret latest research of aldosterone synthase inhibition to manage hypertensive disease states



Presenter(s): 

Daniel Landry, DO, FASN
Chief, Division of Nephrology
Program Director, Nephrology Fellowship
Medical Director, Inpatient Dialysis and Critical Care Nephrology

Melissa Vega, MD
PGY4 Nephrology Fellow

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
 Daniel Landry, DO, FASNSpeakerNo relevant relationships with ineligible companies to discloseNo
Melissa Vega, MDSpeakerNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
06/17/2025 - 12:00pm to 1:00pm EDT
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.